Huib N. Caron

Amore protocol in pediatric head and neck rhabdomyosarcoma: Descriptive analysis of failure patterns

L. Blank, H. Caron, P. Voûte, 2005, Head & neck.

High delta‐like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type

R. Versteeg, H. Caron, C. V. van Noesel, 2003, International journal of cancer.

Upfront treatment of high‐risk neuroblastoma with a combination of 131I‐MIBG and topotecan

H. Caron, M. V. van Noesel, B. van Eck-Smit, 2015, Pediatric blood & cancer.

A worldwide collaboration to harmonize guidelines for the long‐term follow‐up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization Group

H. Caron, M. Hudson, L. Constine, 2013, Pediatric blood & cancer.

Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi

H. Caron, N. van Geloven, M. D. van de Wetering, 2009, Pediatric blood & cancer.

Abstract A30: NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome

R. Bernards, J. Xie, Sidong Huang, 2010 .

N‐myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis

M Schwab, M. Schwab, K. Boon, 2001, The EMBO journal.

Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.

Rogier Versteeg, R. Versteeg, H. Caron, 1996, The New England journal of medicine.